Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
1. U.S. tariff threats on pharmaceuticals may impact European companies significantly. 2. Denmark's pharma sector growth is slowing but remains key to its economy. 3. Novo Nordisk's drug sales significantly boost Denmark's GDP share. 4. Trade policy uncertainty poses risks to pharmaceutical growth in the EU. 5. Live tariffs could drive investment from Europe to the U.S. market.